Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop universal influenza vaccines that induce a more robust immune response against various virus subtypes, including both human and avian strains.
https://www.sciencedaily.com/r....eleases/2025/05/2505